SuperQuick® Human CYP Inhibition Kit (CYP2C9)

DMK-M052

Recombinant CYP450 enzyme subtypes expressed by bacteria, insects, or mammalian cells can be used to study individual CYP metabolic phenotype of drug candidates. Inhibitory effect of drug candidates on individual CYP subtypes, namely CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4, can be investigated by measuring IC50 using selective probe substrates.

In Vitro Drug Metabolism Studies

Recombinant CYP450 enzymes
Substrate
NADPH Regeneration System
0.1 M PBS (pH7.4)

0.2 mL*20 test

Store at -70°C.

Dry ice

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.